Literature DB >> 9387010

Pulmonary myelomonocyte subtypes in drowning and other causes of death.

B Brinkmann1, M A Hernandez, B Karger, C Ortmann.   

Abstract

Three immunohistochemically different myelomonocytic subtypes, i.e. MRP8, MRP14 and 27E10 were quantitatively evaluated in the intraalveolar, alveolar-interstitial and alveolar-intracapillary lung compartments. Lung sections from 5 major groups with defined causes of death, i.e. drowning and death during immersion (DI), cerebral/intracranial haemorrhages (CH), sudden cardiac deaths (SCD), hanging and throttling (HT) and immediate trauma deaths (ITD) were stained and the positive cells counted. The results show clear differences of the cell numbers on average. Among the different compartments the intracapillary cell count exhibits the highest numbers. If the cell counts are compared to the different causes of death, DI shows the highest values and ITD the lowest. The individual values, however, show considerable variations in all compartments and especially in the low cell count range. Within the DI group two subgroups can be differentiated, one having low and the other one having high cell numbers. This can be due to the type of agony, i.e. drowning versus immersion/hydrocution, or to resuscitation attempts or to a combination of both factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9387010     DOI: 10.1007/s004140050091

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  2 in total

1.  Immunohistochemical renal expression of aquaporin 2, arginine-vasopressin, vasopressin receptor 2, and renin in saltwater drowning and freshwater drowning.

Authors:  Rosario Barranco; Francesco Ventura; Tony Fracasso
Journal:  Int J Legal Med       Date:  2020-04-02       Impact factor: 2.686

2.  Differential diagnosis between freshwater drowning and saltwater drowning based on intrapulmonary aquaporin-5 expression.

Authors:  Takahito Hayashi; Yuko Ishida; Shinya Mizunuma; Akihiko Kimura; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2008-05-06       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.